. . . . . . . "[(1) Eight percentage of ductal and 5.7�% non-ductal-type triple negative breast carcinoma present Her-2/neu gene amplification, (2) the standard diagnostic flowchart 'do not FISH in 0-1+ (HER2-) breast carcinoma' should be replaced by 'do FISH in triple (ER-, PR-, HER2-) negative breast carcinoma,' to avoid loss of therapeutical chances in a cohort of such a patients, (3) we demonstrated the identification of a small but significant subset of patients targetable with anti-HER2 inhibitors, giving patients affected by (ex)triple negative breast carcinoma new personalized therapeutical chances.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:12:24+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .